Biologists Figured Out How to Generate New Neurons in the Adult Brain, Revolutionizing Neurodegenerative Disease Research

 

Recently biologists discovered how to generate new neurons in the adult brain. This is an incredible breakthrough that has enormous potential to revolutionize neurodegenerative disease research. By generating genetically-mutated mice with a unique gene that activates dormant neural stem cells, scientists were able to generate new neurons in the brain. For years, scientists have been searching for ways to promote the growth of new neurons in the brain, especially in individuals with neurodegenerative diseases such as Alzheimer’s and Parkinson’s. This new discovery could lead to new treatments and therapies that could help to restore brain function and improve the quality of life for millions of people around the world.

Leslie Samuel, founder of Interactive Biology, gives some context for the importance of genetic trading between organisms for scientific research, and notes how the loss of nerve cells in the brain is one of the hallmarks of neurodegenerative diseases. The ability to generate new neurons in the adult brain could be a game-changer in the field of neurology.

Leslie’s Thoughts

“Anytime you have a situation where extracts from one organism can have beneficial effects on another organism, especially if that other organism is a human, I think it’s an exciting thing. In my last video I spoke about how certain cordyceps fungi can have anti-cancer effects. But it doesn’t stop there.

In fact, studies are beginning to show that some compounds that are extracted from certain species of cordyceps can help to protect neurons from damage and even promote their growth by increasing the production of nerve growth factor. This has potentially huge implications for people suffering with neurodegenerative diseases, things like Alzheimer’s disease or Parkinson’s disease, because these diseases are characterized by a loss of nerve cells in the brain.

So if we can somehow stimulate the exact opposite nerve cell growth, that could be very helpful. But it’s important to understand that we’re still relatively early in this process of studying whether this can be beneficial in therapies in the future. But regardless, it’s awesome to see the progress that’s been made so far, and it’s exciting to think about what that could mean for the future.”

Article written by Galina Mikova.

Follow us on social media for the latest updates in B2B!

Image

Latest

finance
Dr. Silver Kung’s Path From $10 Million in Debt to a Multibillion-Dollar Finance Career
May 21, 2026

Global finance is being tested by forces that no balance sheet can fully predict: unstable supply chains, geopolitical shocks, tighter credit conditions and the accelerating rise of AI. In trade finance especially, success depends on more than capital; it requires judgment, discipline and the ability to see risk before it becomes disruption. As automation…

Read More
specialty pharmacy
At the Center of Care: How Specialty Pharmacy Aligns Patients, Providers, and Payers
May 21, 2026

As healthcare costs continue to rise, more patients are finding themselves navigating not just illness, but the growing complexity of paying for treatment. Specialty pharmacy sits right at the center of that challenge—often out of sight, but increasingly essential to how modern care actually works. These high-cost, high-touch therapies now make up more than…

Read More
Language development
Just Thinking… About How Multilingualism and Language Development Belong at the Center of Student Learning
May 20, 2026

For millions of students in America, learning English is only one part of a much larger academic story. A 2024 GAO report found that English learners in U.S. public schools grew from 4.5 million to 5 million students between fall 2010 and fall 2020, and that they speak more than 400 languages. That diversity…

Read More
AI Infrastructure
Simplifying AI Infrastructure: From Data Center to Deployment (Part 1)
May 19, 2026

In this episode of the Flawless Execution podcast, Jeff Hudgins, VP of Global Services at UNICOM Engineering, breaks down the real-world challenges of deploying AI infrastructure at scale. As AI moves from one-off builds to repeatable global deployments, OEMs, ISVs, and enterprises face increasing complexity across design, integration, cooling, logistics, and installation. Jeff discusses how…

Read More